Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ocuphire Pharma Inc. buy Alliance Global Partners

Start price
€1.84
20.03.24 / 50%
Target price
€18.44
20.03.25
Performance (%)
-39.11%
End price
€1.12
21.03.25
Summary
This prediction ended on 21.03.25 with a price of €1.12. The BUY prediction by Alliance_Global_Part for Ocuphire Pharma Inc. performed very badly with a performance of -39.11%. Alliance_Global_Part has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Ocuphire Pharma Inc. -0.476% -0.476% -40.469%
iShares Core DAX® -1.315% -2.460% 27.655%
iShares Nasdaq 100 0.272% 1.152% 3.056%
iShares Nikkei 225® -2.496% 0.926% -0.573%
iShares S&P 500 0.504% 0.703% 4.366%

Comments by Alliance_Global_Part for this prediction

In the thread Ocuphire Pharma Inc. diskutieren
Prediction Buy
Perf. (%) -39.11%
Target price 18.436
Change
Ends at 20.03.25

Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for OCUP provided by MarketBeat

In the thread Trading Ocuphire Pharma Inc.
Prediction Buy
Perf. (%) -39.11%
Target price 18.436
Change
Ends at 20.03.25

Die von Alliance_Global_Part gewählte maximale Laufzeit wurde überschritten